An insightful and informative Q&A session with Dr. Tejal...

“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale” - Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi

Inside this Issue 1. The 'Amazonization' of Healthcare by Salil Kallianpur Amazon's drive...

The Indian Pharmaceutical Market (IPM) was valued atRs. 10,025 crores in the month of July 2016 clocking a 14.7% growth over same period last year (SPLY). This was the first time ever the market crossed the 10,000 crore mark in a single month.

A big myth about digital transformation is that it...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Strategy and strategic planning are perhaps the most hyped-up...

In a World Economic Forum talk, Professor Sumantra Ghosal - the founding Dean of the Indian School of Business, Hyderabad - talked about the "Smell of the Workplace" as a metaphor to describe the need for creating a new context that enables employees to change their mindset from that of Constraint, Compliance, Control and Contract to that of Stretch, Discipline, Trust and Support.

Ashok Nair began his career as a Medical Rep...

The pill is now a commodity that many of these companies provide at heavy discounts, making money off everything ‘beyond the pill’. Investors are betting heavily on the potential of technological innovation to transform the way healthcare is delivered. The Economic Times reported that in 2021, India recorded investments of $77 billion across 1,266 deals including 164 large deals worth $58 billion. While the money reduced in 2022, the reason wasn’t a lack of faith in this business model. Meanwhile, the pharmaceuticals industry that is most affected by this quiet but rapid change, is grappling with its entrenched culture. Its current business is so profitable that everything else pales in comparison. ‘Build, measure, learn, build again’ – a mantra of the health tech industry is alien to pharma that doesn’t learn, build or measure after launching a product. Pharma also thinks of its customers as doctors alone and does precious little to connect with patients, or caregivers. People who are not sick do not feature on their radar at all. These are cultural values that keep pharma focused on the pill and discourage thinking beyond it. A social media poll conducted by MedicinMan showed almost predictable responses. 100+ respondents who work in the pharma industry in India were quite clearly divided. 48% of them wanted to know what beyond the pill actually meant, while 23% wanted to know how to execute it. The rest felt that the ultra-competitive environment in the Indian generics market required very high share-of-voice tactics (19%), or that their customers demanded product information (9%).

Articles by Anup Soans, K. Hariram, Cambridge Consultants, Sunil Bajaj and Phanish Chandra

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights ...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...